mTOR inhibitors and risk of ovarian cysts: a systematic review and meta-analysis

OBJECTIVE: To summarise the available evidence on frequency of ovarian cyst development during mammalian target of rapamycin inhibitors (mTORi) treatment. METHODS: PubMed/Medline and EMBASE databases were searched, from 1990 up to March 2020, using the following keywords: ‘tacrolimus’, ‘sirolimus’,...

Descripción completa

Detalles Bibliográficos
Autores principales: Parazzini, Fabio, Gerli, Sandro, Favilli, Alessandro, Vignali, Michele, Ricci, Elena, Cipriani, Sonia, Chiaffarino, Francesca, Dell'acqua, Andrea, Harari, Sergio, Bianchi, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475133/
https://www.ncbi.nlm.nih.gov/pubmed/34561260
http://dx.doi.org/10.1136/bmjopen-2020-048190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475133/
https://www.ncbi.nlm.nih.gov/pubmed/34561260
http://dx.doi.org/10.1136/bmjopen-2020-048190

Ejemplares similares